![Lori Macomber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lori Macomber
Finanzdirektor/CFO bei
KARYOPHARM THERAPEUTICS INC.
Vermögen: 774 456 $ am 31.05.2026
Profil
Lori Macomber is Chief Financial Officer, Treasurer & Executive VP at Karyopharm Therapeutics, Inc. since 2025.
Former roles include Chief Financial Officer at Legend Biotech Corp.
from 2022 to 2025, Business Unit Controller at AMETEK, Inc. from 2018 to 2019, Controller & Chief Financial Officer-US Region at Cello Health Ltd. from 2017 to 2018, and Assistant VP-Finance Site Leader at Eli Lilly & Co. from 2010 to 2017.
Education includes undergraduate studies at The Pennsylvania State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 03.02.2026 | 85’105 ( 0.38% ) | 774 456 $ | 31.05.2026 |
Aktive Positionen von Lori Macomber
| Unternehmen | Position | Beginn |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Finanzdirektor/CFO | 03.01.2025 |
Ehemalige bekannte Positionen von Lori Macomber
| Unternehmen | Position | Ende |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Finanzdirektor/CFO | 02.01.2025 |
| AMETEK, INC. | Corporate Officer/Principal | 01.09.2019 |
| CELLO HEALTH PLC | Comptroller/Controller/Auditor | 01.02.2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.04.2017 |
Ausbildung von Lori Macomber
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
AMETEK, Inc.
 AMETEK, Inc. Electrical ProductsProducer Manufacturing Manufactures and supplies electronic instruments and electromechanical devices | Producer Manufacturing |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Cello Health Ltd.
 Cello Health Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company whose subsidiaries provides market research and consulting services | Commercial Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
